US Stocks
—
| # | Ticker | Company | Price | Chg % | Mkt Cap | P/E | EPS Growth TTM | Div Yield | Sector | Return 1Y | Revenue Growth… | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Revolution Medicines, Inc. | $190.46 | 0.2% | $40.49B | -32.0 | -77.3% | — | Healthcare | 419.4% | — | ||
| 2 | Incyte Corporation | $118.05 | 2.1% | $23.58B | 18.4 | 2112.5% | — | Healthcare | 75.5% | 21.5% | ||
| 3 | Genmab A/S | $29.18 | 4.2% | $17.91B | 18.9 | -59.7% | — | Healthcare | 42.2% | -34.4% | ||
| 4 | Exelixis, Inc. | $57.08 | 2.8% | $14.5B | 20.5 | 37.9% | — | Healthcare | 29.3% | 3.3% | ||
| 5 | ImmunityBio, Inc. | $8.76 | -1.7% | $9.17B | -23.1 | -52.4% | — | Healthcare | 222.1% | 351.5% | ||
| 6 | Nuvalent, Inc. | $123.77 | 0% | $9.1B | -21.2 | -38% | — | Healthcare | 58.8% | — | ||
| 7 | Merus N.V. | $90.00 | 0% | $6.83B | -26.9 | -36.9% | — | Healthcare | 71.2% | 55.9% | ||
| 8 | CG Oncology, Inc. Common stock | $69.20 | -0.1% | $6.1B | -33.3 | -53.9% | — | Healthcare | 163.6% | 666% | ||
| 9 | Erasca, Inc. | $18.36 | -2.6% | $5.71B | -41.7 | -50% | — | Healthcare | 1193% | — | ||
| 10 | Celcuity Inc. | $115.72 | 6.6% | $5.64B | -30.6 | -28.4% | — | Healthcare | 767.5% | — | ||
| 11 | Relay Therapeutics, Inc. | $19.74 | 4.4% | $3.73B | -12.3 | 29.6% | — | Healthcare | 456.1% | 39% | ||
| 12 | IDEAYA Biosciences, Inc. | $40.51 | 2.9% | $3.56B | -31.6 | 55.4% | — | Healthcare | 91.4% | 3118.1% | ||
| 13 | Tango Therapeutics, Inc. | $30.12 | 0.6% | $3.5B | -34.6 | 31.4% | — | Healthcare | 454.7% | 39% | ||
| 14 | Enliven Therapeutics, Inc. | $50.92 | 1.8% | $3.1B | -27.8 | 14.6% | — | Healthcare | 159.9% | — | ||
| 15 | Arcus Biosciences, Inc. | $30.25 | 0.9% | $3.05B | -9.2 | 24.6% | — | Healthcare | 268% | 67.4% | ||
| 16 | Day One Biopharmaceuticals, Inc. | $21.53 | 0% | $2.22B | -20.7 | 4.6% | — | Healthcare | 224.7% | 20.6% | ||
| 17 | Syndax Pharmaceuticals, Inc. | $23.24 | 5.3% | $2.05B | -7.1 | 40.3% | — | Healthcare | 166.2% | 396.7% | ||
| 18 | Nuvation Bio Inc. | $5.67 | 1.3% | $1.97B | -9.5 | 81.7% | — | Healthcare | 172.6% | 1205.5% | ||
| 19 | Zymeworks Inc. | $26.72 | 5.5% | $1.97B | -24.7 | 8.1% | — | Healthcare | 104.3% | -13% | ||
| 20 | SELLAS Life Sciences Group, Inc. | $13.50 | -3.2% | $1.92B | -54.0 | 40.3% | — | Healthcare | 522.1% | — | ||
| 21 | Tyra Biosciences, Inc. | $31.94 | 3.5% | $1.9B | -15.9 | -33.7% | — | Healthcare | 232.4% | — | ||
| 22 | UroGen Pharma Ltd. | $37.75 | 0.9% | $1.84B | -11.8 | 13.5% | — | Healthcare | 179.8% | 52.9% | ||
| 23 | Ascentage Pharma Group International | $18.68 | -3.6% | $1.73B | -9.4 | 82.2% | — | Healthcare | -55.6% | 258.7% | ||
| 24 | Immunocore Holdings plc | $33.40 | 4.6% | $1.7B | -63.0 | 11.2% | — | Healthcare | 3.1% | 15.6% | ||
| 25 | Bicara Therapeutics Inc. Common Stock | $30.40 | 4% | $1.67B | -12.1 | -68.5% | — | Healthcare | 237.4% | — | ||
| 26 | ArriVent BioPharma, Inc. Common Stock | $34.18 | -0.9% | $1.59B | -7.9 | 6.4% | — | Healthcare | 69.5% | — | ||
| 27 | Monte Rosa Therapeutics, Inc. | $24.40 | 4.9% | $1.59B | -53.0 | -2757.1% | — | Healthcare | 390.9% | -73.1% | ||
| 28 | Xilio Therapeutics, Inc. | $9.31 | -1.4% | $1.52B | -2.2 | 56.1% | — | Healthcare | -4.9% | 476.7% | ||
| 29 | Inhibrx Biosciences, Inc. | $100.75 | 3.7% | $1.48B | -11.1 | -107.2% | — | Healthcare | 449% | 550% | ||
| 30 | Corvus Pharmaceuticals, Inc. | $15.63 | 3% | $1.31B | -29.5 | 43.9% | — | Healthcare | 300.8% | — | ||
| 31 | ORIC Pharmaceuticals, Inc. | $10.88 | -0.3% | $1.13B | -7.4 | 23% | — | Healthcare | 2.2% | — | ||
| 32 | Olema Pharmaceuticals, Inc. | $12.63 | -1.1% | $1.1B | -6.8 | 1.9% | — | Healthcare | 183.8% | — | ||
| 33 | Kura Oncology, Inc. | $11.99 | 8.6% | $1.06B | -3.8 | -59.5% | — | Healthcare | 111.1% | 5.4% | ||
| 34 | Janux Therapeutics, Inc. | $16.15 | 4.8% | $985M | -8.8 | -35.3% | — | Healthcare | -32.6% | 131.5% | ||
| 35 | Geron Corporation | $1.49 | 3.5% | $956M | -11.5 | 47.9% | — | Healthcare | 8.8% | 68.6% | ||
| 36 | BridgeBio Oncology Therapeutics Inc. | $8.29 | -1.4% | $664M | -1.9 | -289.5% | — | Healthcare | -22.1% | — | ||
| 37 | Immix Biopharma, Inc. | $12.02 | 15% | $654M | -13.5 | -29.6% | — | Healthcare | 358.8% | — | ||
| 38 | Monopar Therapeutics Inc. | $95.22 | -2% | $638M | -51.5 | -30.2% | — | Healthcare | 156% | — | ||
| 39 | Nuvectis Pharma, Inc. | $19.20 | -2.2% | $509M | -14.5 | -18% | — | Healthcare | 144.6% | — | ||
| 40 | Crescent Biopharma, Inc. | $17.03 | 0.4% | $470M | -1.3 | -442.8% | — | Healthcare | 11.4% | — | ||
Showing 40 of 128 stocks